Achieving Localised Delivery With Magnetic Vectoring - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Achieving Localised Delivery With Magnetic Vectoring
Charles E. Seeney tells us about the possibilities of nanotechnology and magnetism, and how a novel approach could improve localised drug delivery.

Pharmaceutical Technology Europe


1. Magnetism in Medicine: A Handbook, Wilfried Andrä and Hannes Nowak, Eds. (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2nd ed., 2007).

2. M.N. Faddis et al., Circulation 106(23), 2980–2985 (2002).

3. M. Baumann et al., Rofo 178(9), 911–917 (2006).

4. J. Klostergaard et al, Future Medicines: Nanomedicine (In press, 2012).

5. R. Bawa, Nanotechnology Law and Business 5, 135–155 (2008).

6. S. Laurent S and M. Mahmoudi, Int. J. Mol. Epidemiol. Genet. 2(4), 367–390 (2011).

7. J. Klostergaard et al., AIP Conference Proceedings (Germany, 2010) pp. 382–387

8. J. Klostergaard et al., J. Magnetism Magnetic Materials 311(1) (2007).

9. C. Plank et al., Expert Opin. Biol. Ther. 3(5), 745–758 (2003).

10. M. Johannsen et al., Int. J. Hyperthermia 21(7), 637–747 (2005).

11. C.E. Seeney et al., Biomaterials, 26(14), (2005).

12. P.Y. Chen et al., Neuro Oncol. 12(10), 1050–60 (2010).

13. M.Y. Hua et al., Biomaterials 32(2), 516–27 (2011).

14. G. Lian et al., Microsc Microanal 10, Suppl. 2 (2004).

15. M. Ma, A: Physicochem. Eng. Aspects 212, 219–226 (2003).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here